Quarterly Statement Of Cash Flows

AFC-HD AMS Life Science Co.,Ltd. - Filing #7294071

Concept As at
2024-08-31
2023-09-01 to
2024-08-31
2022-09-01 to
2023-08-31
As at
2023-08-31
As at
2022-08-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,202,402,000 JPY
1,225,015,000 JPY
Interest and dividends received
11,229,000 JPY
16,265,000 JPY
Interest paid
-97,779,000 JPY
-58,840,000 JPY
Income taxes paid
-575,759,000 JPY
-282,883,000 JPY
Net cash provided by (used in) operating activities
1,540,093,000 JPY
865,280,000 JPY
Cash flows from investing activities
Purchase of investment securities
-1,283,537,000 JPY
-614,290,000 JPY
Proceeds from sale of investment securities
1,074,992,000 JPY
868,762,000 JPY
Loan advances
-62,194,000 JPY
-212,000,000 JPY
Proceeds from collection of loans receivable
62,221,000 JPY
352,000 JPY
Other, net
-2,362,000 JPY
4,937,000 JPY
Net cash provided by (used in) investing activities
-2,761,467,000 JPY
-1,946,009,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
2,172,035,000 JPY
1,684,510,000 JPY
Repayments of long-term borrowings
-486,508,000 JPY
-379,812,000 JPY
Purchase of treasury shares
JPY
-79,568,000 JPY
Dividends paid
-418,804,000 JPY
-385,107,000 JPY
Other, net
-36,559,000 JPY
-51,517,000 JPY
Net cash provided by (used in) financing activities
2,232,074,000 JPY
1,881,171,000 JPY
Effect of exchange rate change on cash and cash equivalents
-2,170,000 JPY
3,799,000 JPY
Net increase (decrease) in cash and cash equivalents
1,008,529,000 JPY
804,242,000 JPY
Cash and cash equivalents
12,070,550,000 JPY
11,062,021,000 JPY
10,257,778,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.